Mikhail Blagosklonny

Last updated
Mikhail Blagosklonny
Alma mater First Pavlov State Medical University of St. Peterburg
Scientific career
Fields Anti-aging medicine, oncology
Institutions

Mikhail Blagosklonny was a scientist who studied cancer and aging. He died in October 2024. He was an adjunct faculty member at Roswell Park Comprehensive Cancer Center in Buffalo, New York. [1]

Contents

Career

Blagosklonny earned both his M.D. in internal medicine and his PhD in experimental medicine and cardiology from the First Pavlov State Medical University of St. Petersburg.[ citation needed ] He was appointed associate professor of medicine at New York Medical College, Valhalla, NY in 2002 before taking a position as a senior scientist at Ordway Research Institute (Albany, New York). Blagosklonny held this position until 2009, when he was appointed professor of oncology at Roswell Park Comprehensive Cancer Center. [2]

Blagosklonny's research interests include cancer and targeted cancer therapies that protect normal cells from damage, as well as the underlying mechanisms of aging (biogerontology) and anti-aging drugs. [3] Roswell Park Comprehensive Cancer Center lists Blagosklonny as holding "Adjunct Faculty" and "Cell Stress Biology" positions with them. [1]

Rapamycin and aging

Blagosklonny has formulated a hypothesis about the possible role of TOR signaling in aging and cancer and proposed using rapamycin, a popular cancer drug as a possible treatment for life extension. [4] He advocates for rapamycin use in longevity research. [5]

Editorial activities

Blagosklonny is editor-in-chief of Aging, [6] Cell Cycle, [7] and Oncotarget . [8] In addition, he is associate editor of Cancer Biology & Therapy [9] and a member of the editorial board of Cell Death & Differentiation . [10]

The peer review process employed by Oncotarget has been criticized by Jeffrey Beall, [11] a university librarian and expert on predatory open access publishing, who also included Oncotarget and Aging on his list of "potential, possible, or probable predatory scholarly open-access journals" [12] in July 2015. [11] Further reports on Beall's blog suggest that the substandard peer review processes for these journals are used by their respective editors-in-chief to entice prospective authors to include references to Blagosklonny's own publications in their articles (following the peer review), thereby raising his personal citation impact. [13]

Health

Blagosklonny announced that in January 2023 he was diagnosed with numerous metastases of lung cancer in his brain. [14] He died in October 2024 at the age of 63. [15]

Related Research Articles

Cell Cycle is a biweekly peer-reviewed scientific journal covering all aspects of cell biology. It was established in 2002 with Mikhail V. Blagosklonny as founding editor-in-chief. Originally published bimonthly, it is now published biweekly.

Dove Medical Press is an academic publisher of open access peer-reviewed scientific and medical journals, with offices in Macclesfield, London, Princeton, New Jersey, and Auckland. In September 2017, Dove Medical Press was acquired by the Taylor and Francis Group.

Allied Academies is a reportedly fraudulent corporation chartered under the laws of North Carolina. Its postal address is in London, United Kingdom. It presents itself as an association of scholars, with supporting and encouraging research and the sharing and exchange of knowledge as its stated aims. The organization consists of 30 affiliate academies, which provide awards to academics and publish academic journals both online and in hard copy for members. Since 2015 the organization has been listed on Jeffrey Beall's list of "potential, possible, or probable predatory scholarly open-access publishers". It is in a partnership with OMICS Publishing Group which uses its website and logo. In 2018, OMICS owner Srinubabu Gedela declared that he had informed the Nevada court that Allied Academies was a subsidiary of OMICS International. During a conference in 2018, they falsely listed a prominent chemist among its organizing committee who had not agreed to this and was not affiliated with Allied Academies.

Wafik El-Deiry is an American physician and cancer researcher who is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, Brown University, Director of the Cancer Center at Brown University, and the Director of the Joint Program in Cancer Biology at Brown University and its affiliated hospitals. He was previously deputy director of Translational Research at Fox Chase Cancer Center, where he was also co-Leader of the Molecular Therapeutics Program.

<span class="mw-page-title-main">Bentham Science Publishers</span> Academic publishing company

Bentham Science Publishers is a company that publishes scientific, technical, and medical journals and e-books. It publishes over 120 subscription-based academic journals and around 40 open access journals.

Scientific Research Publishing (SCIRP) is a predatory academic publisher of open-access electronic journals, conference proceedings, and scientific anthologies that are considered to be of questionable quality. As of December 2014, it offered 244 English-language open-access journals in the areas of science, technology, business, economy, and medicine.

Frontiers Media SA is a publisher of peer-reviewed, open access, scientific journals currently active in science, technology, and medicine. It was founded in 2007 by Kamila and Henry Markram. Frontiers is based in Lausanne, Switzerland, with offices in the United Kingdom, Spain, and China. In 2022, Frontiers employed more than 1,400 people, across 14 countries. All Frontiers journals are published under a Creative Commons Attribution License.

Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. The journal was established in 2010 and is published by Impact Journals. The editors-in-chief are Mikhail Blagosklonny and Andrei V. Gudkov.

<span class="mw-page-title-main">Predatory publishing</span> Fraudulent business model for scientific publications

Predatory publishing, also write-only publishing or deceptive publishing, is an exploitative academic publishing business model, where the journal or publisher prioritizes self-interest at the expense of scholarship. It is characterized by misleading information, deviates from the standard peer review process, is highly non-transparent, and often utilizes aggressive solicitation practices.

Beall's List was a prominent list of predatory open-access publishers that was maintained by University of Colorado librarian Jeffrey Beall on his blog Scholarly Open Access. The list aimed to document open-access publishers who did not perform real peer review, effectively publishing any article as long as the authors pay the article processing charge. Originally started as a personal endeavor in 2008, Beall's List became a widely followed piece of work by the mid-2010s. The list was used by scientists to identify exploitative publishers and detect publisher spam.

<span class="mw-page-title-main">Who's Afraid of Peer Review?</span> 2013 article by John Bohannon

"Who's Afraid of Peer Review?" is an article written by Science correspondent John Bohannon that describes his investigation of peer review among fee-charging open-access journals. Between January and August 2013, Bohannon submitted fake scientific papers to 304 journals owned by fee-charging open access publishers. The papers, writes Bohannon, "were designed with such grave and obvious scientific flaws that they should have been rejected immediately by editors and peer reviewers", but 60% of the journals accepted them. The article and associated data were published in the 4 October 2013 issue of Science as open access.

<span class="mw-page-title-main">Jeffrey Beall</span> American librarian

Jeffrey Beall is an American librarian and library scientist who drew attention to "predatory open access publishing", a term he coined, and created Beall's list, a list of potentially predatory open-access publishers. He is a critic of the open access publishing movement and particularly how predatory publishers use the open access concept, and is known for his blog Scholarly Open Access. He has also written on this topic in The Charleston Advisor, in Nature, in Learned Publishing, and elsewhere.

Aging is a bimonthly peer-reviewed open access bio-medical journal covering research on all aspects of gerontology. The journal was established in 2009 and is published by Impact Journals. The editors-in-chief are Jan Vijg, David Andrew Sinclair, Vera Gorbunova, Judith Campisi, and Mikhail V. Blagosklonny.

Predatory conferences or predatory meetings are meetings set up to appear as legitimate scientific conferences but which are exploitative as they do not provide proper editorial control over presentations, the topics covered can diverge substantially from what has been advertised, and advertising can include claims of involvement of prominent academics who are, in fact, uninvolved. They are an expansion of the predatory publishing business model, which involves the creation of academic publications built around an exploitative business model that generally involves charging publication fees to authors without providing the editorial and publishing services associated with legitimate journals.

Cureus:Journal of Medical Science is a web-based peer-reviewed open access general medical journal using postpublication peer review. It is also the first academic journal which provides authors with step-by-step templates for them to use to write their papers. The journal's founding editors-in-chief are John R. Adler and Alexander Muacevic.

AME Publishing Company is an academic publishing company, which publishes medical journals and books. Founded in July 2009, it is currently headquartered in Hong Kong, with additional offices in Guangzhou, Changsha, Nanjing, Shanghai, Chengdu, Beijing, Taipei, and Hangzhou. Its name stands for "Academic Made Easy/Excellent/Enthusiastic". It has published over 50 medical journals, as well as 20 English-language books, 28 Chinese-language books, and 60 e-books.

Jason W. Locasale is an American scientist and university professor. His focus is on metabolism.

<span class="mw-page-title-main">Torin-1</span> Chemical compound

Torin-1 is a drug which was one of the first non-rapalog derived inhibitors of the mechanistic target of rapamycin (mTOR) subtypes mTORC1 and mTORC2. In animal studies it has anti-inflammatory, anti-cancer, and anti-aging properties, and shows activity against neuropathic pain.

Herald Scholarly Open Access is an Indian publisher of various academic journals. It has a postal address in Herndon, Virginia, United States, but is actually based in Hyderabad, India. Herald Scholarly Open Access has been included on Beall's List of potential predatory open-access publishers, and has faced other criticisms of its publishing practices.

JSci Med Central is a publisher of various academic journals from Hyderabad, India. JSciMed Central has been included on Beall's List of potential predatory open-access publishers, and has faced other criticisms of its publishing practices.

References

  1. 1 2 "About Mikhail Blagosklonny". Roswell Park Comprehensive Cancer Center . Retrieved May 14, 2021.
  2. ↑ "Distinguished physician-scientist, Dr. Mikhail Blagosklonny, joins Roswell Park Cancer Institute", Cancer Biology & Therapy, 8 (9): 753–752, May 2009, doi: 10.4161/cbt.8.9.8899
  3. ↑ "Distinguished physician-scientist, Dr. Mikhail Blagosklonny, joins Roswell Park Cancer Institute". Cancer Biology & Therapy. 8 (9): 753–752. May 2009. doi: 10.4161/cbt.8.9.8899 .
  4. ↑ Stipp, David (2011). "A New Path to Longevity". Scientific American . 306 (1): 32–39. Bibcode:2011SciAm.306f..32S. doi:10.1038/scientificamerican0112-32. PMID   22279832.
  5. ↑ "Does a Real Anti-Aging Pill Already Exist? Inside Novartis's push to produce the first legitimate anti-aging drug, Business Week, 2015". Bloomberg.com. 12 February 2015. Retrieved November 20, 2016.
  6. ↑ "Editorial Board". Aging. Archived from the original on 2009-01-25. Retrieved 2016-11-20.
  7. ↑ "Editorial Board". Cell Cycle. Taylor & Francis . Retrieved 2016-11-20.
  8. ↑ "Editorial Board". Oncotarget. Retrieved 2016-11-20.
  9. ↑ "Editorial board". Cancer Biology & Therapy. Taylor & Francis. Retrieved 2016-11-20.
  10. ↑ "About the journal". Cell Death & Differentiation . Retrieved 2016-11-20.
  11. 1 2 Beall, Jeffrey (19 April 2016). "Oncotarget's Peer Review is Highly Questionable". Scholarly Open Access. Archived from the original on 20 April 2016. Retrieved 2016-11-20.
  12. ↑ Beall, Jeffrey (2016-11-20). "LIST OF STANDALONE JOURNALS: Potential, possible, or probable predatory scholarly open-access journals". Scholarly Open Access. Archived from the original on 2 December 2016. Retrieved 19 April 2016.
  13. ↑ "Mikhail Blagosklonny's Journal Aging: A Review". Scholarly Open Access. 6 December 2016. Archived from the original on 24 December 2016. Retrieved 17 January 2017.
  14. ↑ "My battle with cancer". 26 October 2023.
  15. ↑ "Passing of Dr. Misha Blagoskonny". Rapamycin News. Retrieved 2024-10-09.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.